1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Clinical Trials Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Infectious Disease Clinical Trials Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Vaccines
1.3.3 Cell & Gene Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Clinical Trials Market Perspective (2017-2028)
2.2 Infectious Disease Clinical Trials Growth Trends by Region
2.2.1 Infectious Disease Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Clinical Trials Market Dynamics
2.3.1 Infectious Disease Clinical Trials Industry Trends
2.3.2 Infectious Disease Clinical Trials Market Drivers
2.3.3 Infectious Disease Clinical Trials Market Challenges
2.3.4 Infectious Disease Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Clinical Trials Players by Revenue
3.1.1 Global Top Infectious Disease Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Clinical Trials Revenue
3.4 Global Infectious Disease Clinical Trials Market Concentration Ratio
3.4.1 Global Infectious Disease Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Clinical Trials Revenue in 2021
3.5 Infectious Disease Clinical Trials Key Players Head office and Area Served
3.6 Key Players Infectious Disease Clinical Trials Product Solution and Service
3.7 Date of Enter into Infectious Disease Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Clinical Trials Breakdown Data by Type
4.1 Global Infectious Disease Clinical Trials Historic Market Size by Type (2017-2022)
4.2 Global Infectious Disease Clinical Trials Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Clinical Trials Breakdown Data by Application
5.1 Global Infectious Disease Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Clinical Trials Market Size (2017-2028)
6.2 North America Infectious Disease Clinical Trials Market Size by Country (2017-2022)
6.3 North America Infectious Disease Clinical Trials Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Clinical Trials Market Size (2017-2028)
7.2 Europe Infectious Disease Clinical Trials Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Clinical Trials Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Clinical Trials Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Clinical Trials Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Clinical Trials Market Size (2017-2028)
9.2 Latin America Infectious Disease Clinical Trials Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Clinical Trials Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Clinical Trials Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Clinical Trials Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Infectious Disease Clinical Trials Introduction
11.1.4 IQVIA Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.1.5 IQVIA Recent Development
11.2 LabCorp
11.2.1 LabCorp Company Detail
11.2.2 LabCorp Business Overview
11.2.3 LabCorp Infectious Disease Clinical Trials Introduction
11.2.4 LabCorp Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.2.5 LabCorp Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Infectious Disease Clinical Trials Introduction
11.3.4 Charles River Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.3.5 Charles River Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Detail
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Infectious Disease Clinical Trials Introduction
11.4.4 WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.4.5 WuXi AppTec Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Detail
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Infectious Disease Clinical Trials Introduction
11.5.4 Syneos Health Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.5.5 Syneos Health Recent Development
11.6 PPD
11.6.1 PPD Company Detail
11.6.2 PPD Business Overview
11.6.3 PPD Infectious Disease Clinical Trials Introduction
11.6.4 PPD Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.6.5 PPD Recent Development
11.7 ICON Plc
11.7.1 ICON Plc Company Detail
11.7.2 ICON Plc Business Overview
11.7.3 ICON Plc Infectious Disease Clinical Trials Introduction
11.7.4 ICON Plc Revenue in Infectious Disease Clinical Trials Business (2017-2022)
11.7.5 ICON Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Infectious Disease Clinical Trials Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global Infectious Disease Clinical Trials Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Infectious Disease Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Infectious Disease Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Infectious Disease Clinical Trials Market Share by Region (2017-2022)
Table 10. Global Infectious Disease Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Infectious Disease Clinical Trials Market Share by Region (2023-2028)
Table 12. Infectious Disease Clinical Trials Market Trends
Table 13. Infectious Disease Clinical Trials Market Drivers
Table 14. Infectious Disease Clinical Trials Market Challenges
Table 15. Infectious Disease Clinical Trials Market Restraints
Table 16. Global Infectious Disease Clinical Trials Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Infectious Disease Clinical Trials Market Share by Players (2017-2022)
Table 18. Global Top Infectious Disease Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Clinical Trials as of 2021)
Table 19. Ranking of Global Top Infectious Disease Clinical Trials Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Infectious Disease Clinical Trials Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Infectious Disease Clinical Trials Product Solution and Service
Table 23. Date of Enter into Infectious Disease Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Disease Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Infectious Disease Clinical Trials Revenue Market Share by Type (2017-2022)
Table 27. Global Infectious Disease Clinical Trials Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Infectious Disease Clinical Trials Revenue Market Share by Type (2023-2028)
Table 29. Global Infectious Disease Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Infectious Disease Clinical Trials Revenue Market Share by Application (2017-2022)
Table 31. Global Infectious Disease Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Infectious Disease Clinical Trials Revenue Market Share by Application (2023-2028)
Table 33. North America Infectious Disease Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Infectious Disease Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Infectious Disease Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Infectious Disease Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Infectious Disease Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Infectious Disease Clinical Trials Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Infectious Disease Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Infectious Disease Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Infectious Disease Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Infectious Disease Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 43. IQVIA Company Detail
Table 44. IQVIA Business Overview
Table 45. IQVIA Infectious Disease Clinical Trials Product
Table 46. IQVIA Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 47. IQVIA Recent Development
Table 48. LabCorp Company Detail
Table 49. LabCorp Business Overview
Table 50. LabCorp Infectious Disease Clinical Trials Product
Table 51. LabCorp Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 52. LabCorp Recent Development
Table 53. Charles River Company Detail
Table 54. Charles River Business Overview
Table 55. Charles River Infectious Disease Clinical Trials Product
Table 56. Charles River Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 57. Charles River Recent Development
Table 58. WuXi AppTec Company Detail
Table 59. WuXi AppTec Business Overview
Table 60. WuXi AppTec Infectious Disease Clinical Trials Product
Table 61. WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 62. WuXi AppTec Recent Development
Table 63. Syneos Health Company Detail
Table 64. Syneos Health Business Overview
Table 65. Syneos Health Infectious Disease Clinical Trials Product
Table 66. Syneos Health Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 67. Syneos Health Recent Development
Table 68. PPD Company Detail
Table 69. PPD Business Overview
Table 70. PPD Infectious Disease Clinical Trials Product
Table 71. PPD Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 72. PPD Recent Development
Table 73. ICON Plc Company Detail
Table 74. ICON Plc Business Overview
Table 75. ICON Plc Infectious Disease Clinical Trials Product
Table 76. ICON Plc Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million)
Table 77. ICON Plc Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Clinical Trials Market Share by Type: 2021 VS 2028
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global Infectious Disease Clinical Trials Market Share by Application in 2021 & 2028
Figure 7. Vaccines Case Studies
Figure 8. Cell & Gene Therapy Case Studies
Figure 9. Others Case Studies
Figure 10. Infectious Disease Clinical Trials Report Years Considered
Figure 11. Global Infectious Disease Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Infectious Disease Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Infectious Disease Clinical Trials Market Share by Region: 2021 VS 2028
Figure 14. Global Infectious Disease Clinical Trials Market Share by Players in 2021
Figure 15. Global Top Infectious Disease Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Clinical Trials as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Infectious Disease Clinical Trials Revenue in 2021
Figure 17. North America Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Infectious Disease Clinical Trials Market Share by Country (2017-2028)
Figure 19. United States Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Infectious Disease Clinical Trials Market Share by Country (2017-2028)
Figure 23. Germany Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Infectious Disease Clinical Trials Market Share by Region (2017-2028)
Figure 31. China Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Infectious Disease Clinical Trials Market Share by Country (2017-2028)
Figure 39. Mexico Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Infectious Disease Clinical Trials Market Share by Country (2017-2028)
Figure 43. Turkey Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Infectious Disease Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. IQVIA Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 46. LabCorp Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 47. Charles River Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 48. WuXi AppTec Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 49. Syneos Health Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 50. PPD Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 51. ICON Plc Revenue Growth Rate in Infectious Disease Clinical Trials Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
